Send feedback

CDC20 p.Arg322Ter

c.964C>T · rs372597302 · VCV2443923

Pathogenic No assertion criteria
Classification
Pathogenic
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
Consequence
nonsense (stop-gain)
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00667%, afr)
Conditions
1
oocyte maturation defect 14

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequencenonsense (stop-gain)predicted loss-of-function
NMDpredictedpremature termination codon in exon 8 of 11
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6GERP 0.012, phastCons 1
Overall
CADD38.0PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00667% African / African-American · 5/74,910 alleles
Filtering AF 0.00255% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00161%
Overall 0.00192% 31/1,613,928 alleles · very rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00667% 14,982
Remaining individualsnot grpmax-eligible 0.0048% 20,826
East Asian 0.00223% 44,888
European (non-Finnish) 0.00178% 56,187
South Asian 0.0011% 91,080

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CDC20
Protein
p.Arg322Ter
Coding
c.964C>T
MANE Select
NM_001255
dbSNP
rs372597302
Type
single nucleotide variant
Location
chr1:43360848 (GRCh38)
Gene constraint
LOEUF 0.744 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.39 · 17 PDB
Residue 322
a UniProt-annotated variant site (in ozema14; severely decreased function in metaphase/anaphase transition of meiosis i; does not fully rescue metaphase i arrest in cdc20-knocked down mouse oocytes; decreased function in positive regulation of anaphase-promoting complex-dependent catabolic process; fails to localize to the kinetochore); a UniProt-annotated variant site (in ozema14); a UniProt-annotated variant site (in ozema14; severely decreased function in metaphase/anaphase transition of meiosis i; does not fully rescue metaphase i arrest in cdc20-knocked down mouse oocytes; decreased function in positive regulation of anaphase-promoting complex-dependent catabolic process; shows normal kinetochore localization); a β-strand
Full CDC20 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdc20-p-arg322ter (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown